Ceftazidime-Avibactam as Salvage Therapy in Pediatric Liver Transplantation Patients with Infections Caused by Carbapenem-Resistant Enterobacterales

OBJECTIVE: There are few therapeutic options for infections caused by carbapenem-resistant Enterobacterales (CRE) in children following liver transplantation. Ceftazidime-avibactam (CAZ-AVI), a recently licensed antibacterial in China, was utilized as a salvage therapy against CRE in our center, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Weili, Wang, Rongrong, Zhang, Yuntao, Zeng, Lei, Kong, Haisen, Bai, Xueli, Zhang, Wei, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241992/
https://www.ncbi.nlm.nih.gov/pubmed/35782529
http://dx.doi.org/10.2147/IDR.S369368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241992/
https://www.ncbi.nlm.nih.gov/pubmed/35782529
http://dx.doi.org/10.2147/IDR.S369368

Ejemplares similares